Brad A Racette1, Susan Searles Nielsen2, Susan R Criswell2, Lianne Sheppard2, Noah Seixas2, Mark N Warden2, Harvey Checkoway2. 1. From the Department of Neurology (B.A.R., S.S.N., S.R.C., M.N.W.), Washington University School of Medicine, St. Louis, MO; School of Public Health, Faculty of Health Sciences (B.A.R.), University of the Witwatersrand, Johannesburg, South Africa; Department of Environmental and Occupational Health Sciences (L.S., N.S.), University of Washington, Seattle; and Department of Family Medicine and Public Health (H.C.), University of California, San Diego. racetteb@neuro.wustl.edu. 2. From the Department of Neurology (B.A.R., S.S.N., S.R.C., M.N.W.), Washington University School of Medicine, St. Louis, MO; School of Public Health, Faculty of Health Sciences (B.A.R.), University of the Witwatersrand, Johannesburg, South Africa; Department of Environmental and Occupational Health Sciences (L.S., N.S.), University of Washington, Seattle; and Department of Family Medicine and Public Health (H.C.), University of California, San Diego.
Abstract
OBJECTIVE: To determine whether the parkinsonian phenotype prevalent in welders is progressive, and whether progression is related to degree of exposure to manganese (Mn)-containing welding fume. METHODS: This was a trade union-based longitudinal cohort study of 886 American welding-exposed workers with 1,492 examinations by a movement disorders specialist, including 398 workers with 606 follow-up examinations up to 9.9 years after baseline. We performed linear mixed model regression with cumulative Mn exposure as the independent variable and annual change in Unified Parkinson Disease Rating Scale motor subsection part 3 (UPDRS3) as the primary outcome, and subcategories of the UPDRS3 as secondary outcomes. The primary exposure metric was cumulative Mn exposure in mg Mn/m3-year estimated from detailed work histories. RESULTS: Progression of parkinsonism increased with cumulative Mn exposure. Specifically, we observed an annual change in UPDRS3 of 0.24 (95% confidence interval 0.10-0.38) for each mg Mn/m3-year of exposure. Exposure was most strongly associated with progression of upper limb bradykinesia, upper and lower limb rigidity, and impairment of speech and facial expression. The association between welding exposure and progression appeared particularly marked in welders who did flux core arc welding in a confined space or workers whose baseline examination was within 5 years of first welding exposure. CONCLUSIONS: Exposure to Mn-containing welding fume may cause a dose-dependent progression of parkinsonism, especially upper limb bradykinesia, limb rigidity, and impairment of speech and facial expression.
OBJECTIVE: To determine whether the parkinsonian phenotype prevalent in welders is progressive, and whether progression is related to degree of exposure to manganese (Mn)-containing welding fume. METHODS: This was a trade union-based longitudinal cohort study of 886 American welding-exposed workers with 1,492 examinations by a movement disorders specialist, including 398 workers with 606 follow-up examinations up to 9.9 years after baseline. We performed linear mixed model regression with cumulative Mn exposure as the independent variable and annual change in Unified Parkinson Disease Rating Scale motor subsection part 3 (UPDRS3) as the primary outcome, and subcategories of the UPDRS3 as secondary outcomes. The primary exposure metric was cumulative Mn exposure in mg Mn/m3-year estimated from detailed work histories. RESULTS: Progression of parkinsonism increased with cumulative Mn exposure. Specifically, we observed an annual change in UPDRS3 of 0.24 (95% confidence interval 0.10-0.38) for each mg Mn/m3-year of exposure. Exposure was most strongly associated with progression of upper limb bradykinesia, upper and lower limb rigidity, and impairment of speech and facial expression. The association between welding exposure and progression appeared particularly marked in welders who did flux core arc welding in a confined space or workers whose baseline examination was within 5 years of first welding exposure. CONCLUSIONS: Exposure to Mn-containing welding fume may cause a dose-dependent progression of parkinsonism, especially upper limb bradykinesia, limb rigidity, and impairment of speech and facial expression.
Authors: Susan R Criswell; Joel S Perlmutter; John L Huang; Nima Golchin; Hubert P Flores; Angela Hobson; Michael Aschner; Keith M Erikson; Harvey Checkoway; Brad A Racette Journal: Occup Environ Med Date: 2012-03-23 Impact factor: 4.402
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Lan Kong; Jeff D Yanosky; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2019-04-01 Impact factor: 4.849
Authors: Susan R Criswell; Susan Searles Nielsen; Mark N Warden; Hubert P Flores; Jason Lenox-Krug; Sophia Racette; Lianne Sheppard; Harvey Checkoway; Brad A Racette Journal: J Occup Environ Med Date: 2019-08 Impact factor: 2.162
Authors: Swaantje Casjens; Urike Dydak; Shalmali Dharmadhikari; Anne Lotz; Martin Lehnert; Clara Quetscher; Christoph Stewig; Benjamin Glaubitz; Tobias Schmidt-Wilcke; David Edmondson; Chien-Lin Yeh; Tobias Weiss; Christoph van Thriel; Lennard Herrmann; Siegfried Muhlack; Dirk Woitalla; Michael Aschner; Thomas Brüning; Beate Pesch Journal: Neurotoxicology Date: 2017-08-11 Impact factor: 4.294
Authors: Marissa G Baker; Yvonne S Lin; Christopher D Simpson; Laura M Shireman; Susan Searles Nielsen; Brad A Racette; Noah Seixas Journal: J Trace Elem Med Biol Date: 2018-11-03 Impact factor: 3.849
Authors: Sian Genoud; Blaine R Roberts; Adam P Gunn; Glenda M Halliday; Simon J G Lewis; Helen J Ball; Dominic J Hare; Kay L Double Journal: Metallomics Date: 2017-10-18 Impact factor: 4.526